Polymorphism of the parasite lactate dehydrogenase gene from Plasmodium vivax Korean isolates
Thursday, May 23, 2013 at 4:27PM View Malaria Journal article here
KEYWORD SEARCH
Other News and Resources
Thursday, May 23, 2013 at 4:27PM View Malaria Journal article here
Thursday, May 23, 2013 at 4:26PM View Malaria Journal article here
Monday, May 20, 2013 at 4:47PM Dr Fatoumata Nafo-Traoré, executive director of Roll Back Malaria talks about her career and calls for a rights-based approach to development.
View The Guardian interview here
Friday, May 17, 2013 at 4:41PM View Malaria Journal article here
Tuesday, May 7, 2013 at 3:58PM
Wednesday, May 1, 2013 at 12:11PM View Malaria Journal article here
Monday, April 29, 2013 at 12:15PM View Nature Genetics article here
Friday, April 26, 2013 at 5:17PM
Monday, April 22, 2013 at 1:54PM View PLOS Neglected Tropical Diseases article here
Thursday, April 18, 2013 at 12:34PM View Malaria Journal article here
Tuesday, April 16, 2013 at 12:50PM View Malaria Journal article here
Tuesday, April 16, 2013 at 12:48PM View Malaria Journal article here
Monday, April 15, 2013 at 12:52PM View Transitions of the Royal Society of Tropical Medicine & Hygiene article here
Friday, April 12, 2013 at 12:55PM View Malaria Journal article here
Tuesday, April 2, 2013 at 5:39PM View Vanuatu Daily Post article here
Saturday, March 30, 2013 at 5:00PM Voew PLOS ONE article here
Thursday, March 28, 2013 at 9:50AM View Malaria Journal article here
Wednesday, March 27, 2013 at 4:16PM View Malaria Journal article here
Tuesday, March 26, 2013 at 10:38AM May 28 - 29, 2013
Barcelona, Spain
CosmoCaixa, Barcelona
Malaria accounts for approximately 250 million clinical cases and nearly 1 million deaths annually, mostly in children, in 109 countries. There has been growing evidence that Plasmodium vivax is the most widely distributed malaria parasite, responsible for a significant burden of global disease and accounting for the majority of malaria cases in Latin America and Asia. Despite the increasing awareness that the overall burden, economic impact, and severity of P. vivax disease have been underestimated, this species remains underrepresented in the scientific literature and professional fora.
This 2-day conference will convene a global community of researchers to discuss P. vivax molecular biology and genomics, host–parasite interactions, novel research techniques (e.g., 'omics) to overcome barriers to in vitro, in vivo, and clinical study of P. vivax; drug resistance and drug discovery; and recent clinical trial and in-field efforts in P. vivax prevention, treatment, control, and elimination.
Presented by The New York Academy of Sciences, the "la Caixa" Foundation, B-DEBATE, Barcelona Institute for Global Health (ISGlobal), and the Barcelona Centre for International Health Research (CRESIB)
Please click here for more information
The information, views, and opinions contained in these articles are those of the respective author’s and do not necessarily reflect the views and opinions of APMEN or its participants or affiliates. The links are provided for the convenience of the reader and not as an endorsement of their contents.